This established model comprises eight indices for clinical application: BCLC staging, tumor number, presence of distant metastasis, ascites, age ≥60 years, aspartate aminotransferase ≥40 ug/L, albumin <35 g/L, and alkaline phosphatase ≥125 ug/L. This evidence concerns the gene ALB and neoplasm.